3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
16
Phase 1
9
Phase 3
4
Phase 1/2
3
Phase NA
1
Phase EARLY_PHASE1
1
Phase 2/3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Head and Neck Neoplasms
4
Stomach Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Medulloblastoma
2
Fallopian Tube Neoplasms
2
Tonsillar Neoplasms
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Prostatic Neoplasms
1
Pinealoma
1
Pharyngeal Neoplasms
1
Pelvic Neoplasms
1
Pancreatic Adenocarcinoma
1
Ototoxicity
1
Neuroectodermal Tumors, Primitive
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Mesothelioma, Malignant
1
Lymphoma, B-Cell
1
Liposarcoma
1
Hepatoblastoma
1
Esophageal Squamous Cell Carcinoma
1
EGFR Positive Non-small Cell Lung Cancer
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Interventions
pembrolizumab
3
Oncolytic Virotherapy
3
Magnetic Resonance Spectroscopy
3
Specimen Handling
2
Radiotherapy
2
Nivolumab
2
Irinotecan
2
Doxorubicin
2
Cyclophosphamide
2
trastuzumab biosimilar HLX02
1
sodium thiosulfate
1
pertuzumab
1
perflutren
1
palbociclib
1
olaparib
1
niraparib
1
montelukast
1
eribulin
1
entrectinib
1
cobimetinib
1
camrelizumab
1
atezolizumab
1
apatinib
1
alovudine
1
alectinib
1
X-Rays
1
Vinorelbine
1
Vincristine
1
Vemurafenib
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Sarcoma
×
Cisplatin
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled